Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-08-15
2006-08-15
Harris, Alana M. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S007210, C435S007230, C435S007920, C435S007930, C435S007940, C436S063000, C436S064000, C436S086000, C530S300000, C530S350000, C530S385000, C530S386000, C530S387100, C530S387700, C530S388100
Reexamination Certificate
active
07090983
ABSTRACT:
MK (midkine) was found to rise in the blood or urine of patients with various types of cancers at early stage. Based on this finding, a method for detecting early cancer, comprising the step of measuring MK in blood or urine was completed.
REFERENCES:
patent: 6-113898 (1994-04-01), None
patent: 6-172218 (1994-06-01), None
patent: WO 00/31541 (1994-06-01), None
Ye et al. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. British Journal of Cancer 79(1); 179-184, Jan. 1999.
Lederman, et al. A single amino acid substitution in a common african allele of the CD4 molecule ablastes binding of the monoclonal antibody, OKT4. Molecular Immunology 28(11): 1171-1181, 1991.
Li et al., Beta-endorphin omission analogs: Dissociatian of immunoreactivity from other biological activities. Proc. Natl. Acad. Sci. USA 77(6):3211-3214, Jun. 1980.
Song et al. The Serum Level of Midkine, A Heparin-binding growth factor, as a tumor marker. Biomedical Research 18(5): 375-381, 1997.
Nakagaware et al. “Differential Expression of Pleiotrophin and Midkine in Advanced Neuroblastomas”Cancer Research55(8):1792-1797, 1995.
Ye et al. “Expression of midkine in the early stage of carcinogenesis in human colorectal cancer”British J. Cancer79(1):179-184, Jan. 1999.
Aridome, K., J. Tsutsui, S. Takao, K. Kadomatsu, M. Ozawa, T. Aikou, and T. Muramatsu. “Increased midkine gene expression in human gastrointestinal cancers.”Jpn. J. Cancer Res.Jul., 1995. 86:655-661.
Garver, R.I., D.M. Radford, H. Donis-Keller, M.R. Wick, and P.G. Milner. “Midkine and pleiotrophin expression in normal and malignant breast tissue.”Cancer.Sep. 1, 1994. 74(5): 1584-1590.
Ikematsu, S., A. Yano, K. Aridome, M. Kikuchi, H. Kumai, H. Nagano, K. Okamoto, M. Oda, S. Sakuma, T. Aikou, H. Muramatsu, K. Kadomatsu, and T. Muramatsu. “Serum midkine levels are increased in patients with various types of carcinomas.”Br. J. Cancer.2000. 83(6): 701-706.
Koide, N., H. Hada, T. Shinji, K. Ujike, S. Hirasaki, Y. Yumoto, T. Hanafusa, K. Kadomatsu, H. Muramatsu, T. Muramatsu, and T. Tsuji. “Expression of the midkine gene in human hepatocellular carcinomas.”Hepato-Gastroenterology.1999. 46: 3189-3196.
Konishi, N., M. Nakamura, S. Nakaoka, Y. Hiasa, M. Cho, H. Uemura, Y. Hirao, T. Muramatsu, and K. Kadomatsu. “Immunohistochemical analysis of midkine expression in human prostate carcinoma.”Oncology.1999. 57: 253-257.
Muramatsu, H., et al. “Enzyme-linked immunoassay for midkine, and its application to evaluation of midkine levels in developing mouse brain and sera from patients with hepatocellular carcinomas.”J. Biochem.1996. 119: 1171-1175.
Tsutsui, J., K. Kadomatsu, S. Matsubara, A. Nakagawara, M. Hamanoue, S. Takao, H. Shimazu, Y. Ohi, and T. Muramatsu. “A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas,”Cancer Res.1993. 53: 1281-1285.
Aridome, K. et al., “Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas,”British Journal of Cancer(1998), vol. 78, No. 4, pp. 472-477.
Rha, S.Y. et al., “Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate,”Cancer Letters(1997), vol. 118, No. 1, pp. 37-46.
Ikematsu Shinya
Kumai Hideshi
Muramatsu Takashi
Oda Munehiro
Okamoto Kohji
Harris Alana M.
Muramatsu, Takashi
LandOfFree
Methods for detecting early cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting early cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting early cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3614055